EORTCMYC is a highly desirable oncogenic target that historically eluded drug huntersSmall molecules that inhibit the oncogenic function of MYC were discovered using Dewpoint’s AI/ML and condensate ...

Primary CLL cells were evaluated by flow cytometry using a LSRFortessa Cell Analyzer (BD Biosciences, Milan, Italy) for NPM1 expression (0412; Santa Cruz Biotechnology, Dallas, TX, USA), total NOTCH1 ...

Race Oncology has achieved a breakthrough with its lead drug candidate RC220, identifying for the first time the primary ...

Arima Genomics announces a new study showing that the Aventa™ lymphoma test resolves diagnostic ambiguity and guides care in ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or ...

A research team has outlined how synthetic biology can accelerate discoveries in plant–microbe interactions, offering ...

Ohio State football’s Tavien St. Clair had his black stripe removed Tuesday, the program announced via social media. The ...

Instead of acting like older chemotherapy drugs, RCDS1 targets special structures in DNA and RNA called G-quadruplexes (G4s), which control important cancer genes like MYC. "By doing this, the drug ...

The ASX rallied strongly by 1% at Thursday lunch in the east, looking every bit like a market that had finally found its mojo ...

Dr. Sutera opened his talk by outlining that he would divide his presentation into three parts: first, defining MMAI; second, discussing its application in oligometastatic prostate cancer; and third, ...

For decades, evidence guiding the diagnosis of postpartum haemorrhage has been constrained by traditional aggregate data ...